Skip to main content

delafloxacin (Quofenix®)


Appraisal in progress


Status: In progress

For the treatment of the following infections in adults: acute bacterial skin and skin structure infections (ABSSSI); community-acquired pneumonia (CAP), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections.

Medicine details

Medicine name delafloxacin (Quofenix®)
Formulation 300 mg powder for concentrate for solution for infusion; 450 mg tablet
Reference number 4402

As above

Company A. Menarini Farmaceutica Internazionale SRL
BNF chapter Infections
Submission type Full
Status In progress
NMG meeting date TBC
AWMSG meeting date TBC
Date of issue TBC